ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither (BMJ, 1998)

(untitled) - Baigent, C; Collins, R; Appleby, P; Parish, S; Sleight, P; Peto, R